Number of Shares
181,712.00
Current Holdings Value*
£3.43 Mil
% of Portfolio
3.73%
Total Estimate Gain
£-423,530.13
% of Total Estimate Gain
-3.85%

BNY Mellon International Core Equity Fund's GSK PLC Holding Summary

As of 2025-03-31, BNY MELLON STOCK FUNDS held 181,712.00 shares of GSK PLC(LSE:GSK), totaling £3.43 Mil. This investment constitutes 3.73% of their stock portfolio, and BNY MELLON STOCK FUNDS now holds 0% of the outstanding GSK PLC(LSE:GSK) stock.

The initial trade took place in 2019Q3. And since then BNY Mellon International Core Equity Fund has made 5 purchases of LSE:GSK, at an average price of £16.22, for a total of 678,507.20 shares. In addition, there have been 14 sales at an average price of £16.21 for 496,795.20 shares. Based on historical transaction data and LSE:GSK's current price of £13.91, BNY Mellon International Core Equity Fund's estimated gain on his LSE:GSK holdings is £-423,530.13, reflecting a -3.85% gain to date.

BNY Mellon International Core Equity Fund LSE:GSK (£13.91) Holding Chart

BNY Mellon International Core Equity Fund LSE:GSK (£13.91) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price £-/Share
Shares Sold 0 Average Price £-/Share
Current Price £0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1